L Wramner
Overview
Explore the profile of L Wramner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bechstein W, Paczek L, Wramner L, Squifflet J, Zygmunt A
Transplant Proc
. 2013 Aug;
45(6):2133-40.
PMID: 23953523
Background: The clinical safety and efficacy of sirolimus plus reduced-dose tacrolimus was evaluated in de novo renal allograft recipients enrolled in a comparative, open-label study. Methods: One hundred twenty-eight renal...
2.
Backman L, Reisaeter A, Wramner L, Ericzon B, Salmela K, Brattstrom C
Clin Transplant
. 2006 Jul;
20(3):336-9.
PMID: 16824151
Two Six-month pilot studies were conducted in renal (n = 17) or liver (n = 15) transplant recipients to evaluate renal function after conversion from calcineurin inhibitor (CI)- to sirolimus...
3.
Charpentier B, Groth C, Backman L, Morales J, Calne R, Kreis H, et al.
Transplant Proc
. 2003 May;
35(3 Suppl):58S-61S.
PMID: 12742468
In 11 European centers, first cadaveric renal allograft recipients were randomized to CsA (n = 42) or sirolimus (n = 41). Dosing of these agents was concentration-controlled and open-labeled. All...
4.
Wramner L, Norden G, Herlenius G, Friman S, Olausson M, Backman L
Transplant Proc
. 2003 Mar;
35(2):791.
PMID: 12644139
No abstract available.
5.
Herlenius G, Friman S, Backman L, Krantz M, Saalman R, Ascher H, et al.
Transplant Proc
. 2002 May;
34(3):865.
PMID: 12034211
No abstract available.
6.
Hanson L, Padyukov L, Strandvik B, Wramner L
Lakartidningen
. 2000 May;
97(15):1823-6.
PMID: 10815410
The immune system is closely integrated with the neuroendocrine system, and infection-induced increases in cytokines such as IL-1, IL-6 and TNF have numerous effects on the central nervous system. These...
7.
Kreis H, Cisterne J, Land W, Wramner L, Squifflet J, Abramowicz D, et al.
Transplantation
. 2000 May;
69(7):1252-60.
PMID: 10798738
Introduction: A previous trial in renal transplantation comparing sirolimus (rapamycin) to cyclosporine (CsA) in a triple-drug therapy regimen with azathioprine and corticosteroids found that the incidence of acute rejection was...
8.
Groth C, Backman L, Morales J, Calne R, Kreis H, Lang P, et al.
Transplantation
. 1999 Apr;
67(7):1036-42.
PMID: 10221490
Background: Sirolimus (rapamycin) is a potent immunosuppressant with a mechanism of action different from cyclosporine (CsA) or tacrolimus. Methods: In 11 European centers, first cadaveric renal allograft recipients were randomized...
9.
Salmela K, Wramner L, Ekberg H, Hauser I, Bentdal O, Lins L, et al.
Transplantation
. 1999 Mar;
67(5):729-36.
PMID: 10096530
Background: T-cell activation through T-cell receptor engagement requires co-stimulatory molecules and also adhesion molecules such as ICAM-1. Moreover ICAM-1 mediates leukocyte invasion from the blood into tissue during inflammatory processes....
10.
Olausson M, Wramner L, Blohme I, Mjornstedt L
Transplant Proc
. 1997 Nov;
29(7):3127-8.
PMID: 9365695
No abstract available.